NASDAQ:MASI - Masimo Stock Price, Forecast & News

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Masimo Co. (NASDAQ:MASI) posted its quarterly earnings data on Wednesday, October, 30th. The medical equipment provider reported $0.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.73 by $0.03. The medical equipment provider earned $229.01 million during the quarter, compared to the consensus estimate of $221.92 million. Masimo had a net margin of 20.83% and a return on equity of 17.32%. Masimo's quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.71 EPS. View Masimo's Earnings History.

Masimo is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Masimo.

Masimo will be holding an earnings conference call on Wednesday, February 19th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Masimo updated its FY 2019 Pre-Market earnings guidance on Tuesday, January, 14th. The company provided earnings per share (EPS) guidance of 3.18 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.17. The company issued revenue guidance of $934-937 million, compared to the consensus revenue estimate of $947.01 million.

6 analysts have issued 1-year target prices for Masimo's stock. Their forecasts range from $134.50 to $190.00. On average, they expect Masimo's share price to reach $167.08 in the next year. This suggests that the stock has a possible downside of 7.9%. View Analyst Price Targets for Masimo.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Masimo.

News coverage about MASI stock has trended somewhat negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Masimo earned a daily sentiment score of -1.6 on InfoTrie's scale. They also gave media coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Masimo.

Masimo saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 999,000 shares, a decrease of 34.7% from the January 15th total of 1,530,000 shares. Based on an average daily volume of 323,800 shares, the short-interest ratio is presently 3.1 days. Approximately 2.0% of the shares of the company are sold short. View Masimo's Current Options Chain.

Some companies that are related to Masimo include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Mastercard (MA), Paypal (PYPL), Shopify (SHOP), Twilio (TWLO), Trade Desk (TTD) and Visa (V).

Masimo's stock is owned by a variety of of retail and institutional investors. Top institutional investors include FMR LLC (8.82%), Citigroup Inc. (2.88%), Massachusetts Financial Services Co. MA (2.49%), State Street Corp (2.23%), Champlain Investment Partners LLC (2.00%) and Bank of New York Mellon Corp (1.86%). Company insiders that own Masimo stock include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

MASI stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., AQR Capital Management LLC, Victory Capital Management Inc., Victory Capital Management Inc., First Trust Advisors LP, Renaissance Technologies LLC, Bank of New York Mellon Corp and Janus Henderson Group PLC. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Bilal Muhsin, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo.

MASI stock was acquired by a variety of institutional investors in the last quarter, including Citigroup Inc., FMR LLC, Massachusetts Financial Services Co. MA, Westfield Capital Management Co. LP, Bank of Montreal Can, Champlain Investment Partners LLC, TD Asset Management Inc. and UBS Group AG. View Insider Buying and Selling for Masimo.

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MASI stock can currently be purchased for approximately $181.49.

Masimo has a market capitalization of $9.68 billion and generates $858.29 million in revenue each year. The medical equipment provider earns $193.54 million in net income (profit) each year or $3.03 on an earnings per share basis. Masimo employs 1,500 workers across the globe.View Additional Information About Masimo.

The official website for Masimo is http://www.masimo.com/.

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]